The government has begun speeding up approvals in the area of clinical research which is set to boom in India, say top industry sources. The clinical research industry in India is currently $200 million, but is expected to reach $1.5 billion in just two years.

“The government is proactively improving the regulatory framework to speed up approvals. So, the proper safeguards need to be in place to ensure this growth but also protect the people,” Drug Controller General of India (DCGI) Surinder Singh said.

The government is also planning on introducing fingerprinting of clinical trial volunteers to ensure better data from the trails and also regularise insurance claims by these volunteers.

More at ET